Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C24H23N5O2 |
| Molecular Weight | 413.4717 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[O-][N+]1=CC=C(CNC2=NC=CC=C2C(=O)NC3=CC=C(C=C3)C4(CCCC4)C#N)C=C1
InChI
InChIKey=ZIPYWOHLEIKVDH-UHFFFAOYSA-N
InChI=1S/C24H23N5O2/c25-17-24(11-1-2-12-24)19-5-7-20(8-6-19)28-23(30)21-4-3-13-26-22(21)27-16-18-9-14-29(31)15-10-18/h3-10,13-15H,1-2,11-12,16H2,(H,26,27)(H,28,30)
| Molecular Formula | C24H24N5O2 |
| Molecular Weight | 414.4797 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Thu Jul 06 23:14:47 UTC 2023
by
admin
on
Thu Jul 06 23:14:47 UTC 2023
|
| Record UNII |
T2N3HYQ3HA
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1376710-40-5
Created by
admin on Thu Jul 06 23:14:48 UTC 2023 , Edited by admin on Thu Jul 06 23:14:48 UTC 2023
|
PRIMARY | |||
|
T2N3HYQ3HA
Created by
admin on Thu Jul 06 23:14:48 UTC 2023 , Edited by admin on Thu Jul 06 23:14:48 UTC 2023
|
PRIMARY | |||
|
71313461
Created by
admin on Thu Jul 06 23:14:48 UTC 2023 , Edited by admin on Thu Jul 06 23:14:48 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
BINDER->LIGAND |
BINDING
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE |
FECAL
|
||
|
PARENT -> METABOLITE |
MAJOR
PLASMA
|
||
|
PARENT -> METABOLITE |
URINE
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Biological Half-life | PHARMACOKINETIC |
|
DOSE |
|
||
| Tmax | PHARMACOKINETIC |
|
AT DAY 28 |
|
||